Biotech

All Articles

Amgen records 1st phase 3 gain for $400M eczema medicine

.Amgen has discussed (PDF) the first stage 3 data on its $400 thousand chronic eczema drug, connecti...

Biogen, UCB report period 3 lupus win after stopping working earlier test

.Biogen and also UCB's bet one's bottom dollar improving in to phase 3 astride a failed research wan...

Aptadir really hopes new RNA preventions can reverse complicated cancers cells

.Italian biotech Aptadir Rehabs has introduced along with the guarantee that its pipe of preclinical...

Wave surfs DMD success to regulatory authorities' doors, sending out stockpile

.Surge Lifestyle Sciences has satisfied its own objective in a Duchenne muscle dystrophy (DMD) resea...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fold...

Achilles drips tissue therapy course, braces for layoffs after overlooking 'industrial stability' targets

.Achilles Rehabs has actually destroyed its own method. The English biotech is actually stopping wor...

Aligos declares period 2 MASH gain, lowering liver excess fat approximately 46%

.Aligos Therapies is actually declaring a midstage gain in metabolic-dysfunction affiliated steatohe...

Basilea ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job establishing brand new antifungals has gotten a notable boost from the ...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Possessing actually scooped up the united state civil rights to Capricor Rehabs' late-stage Duchenn...

FDA scraps adcomm for Applied's unusual condition drug

.After dismissing the selection date for Applied Therapies' metabolic problem drug govorestat, the F...